Latest Biotechnology, Pharmaceutical and Healthcare News

03:34 EDT 21st May 2018 | BioPortfolio

Showing News Articles 1–25 of 430,000+

Monday 21st May 2018

WideCells Group says 2017 financial statements nearing completion

The additional time required to finalise the results mean its live bookbuild via the Teathers mobile app has been extended until the figures are released

GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines

GC Pharma, IDRI and MIBR Bringing Together to Develop Innovative Vaccines YONGIN, South Korea, May 20, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced the establishment of Curevo Inc. ("Curevo"). The newly established Seattle-based company's goal...

Three new cyathane diterpenes with neurotrophic activity from the liquid cultures of Hericium erinaceus

Roche’s Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in haemophilia A without factor VIII inhibitors

Roche today announced full results from the phase III HAVEN 3 study evaluating Hemlibra® (emicizumab) prophylaxis administered every week or every two weeks in people with haemophilia A without factor VIII inhibitors and the phase III HAVEN 4 study evaluating Hemlibra prophylaxis administered every four weeks in people with haemophilia A with or without factor VIII inhibitors.

Sofinnova Partners Appoints Dr. Martin T. Rothman as Venture Partner

Sofinnova Partners significantly reinforces its team with an internationally renowned physician and entrepreneur Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, has appointed Dr. Martin T. Rothman as Venture Partner. Dr. Rothman brings forty years of experience and a strong international network in the medical ...

UTILITY Receives Qualified Infectious Disease Product Designation from the U.S. FDA

UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercialising antibiotics in the US, today announced that the U.S. Food and Drug Administration (FDA) has designated both mecillinam (injectable) and pivmecillinam (oral prodrug) as Qualified Infectious Disease Products (QIDP) for the indication of ...

Genentech’s HEMLIBRA (emicizumab-kxwh) Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Hemophilia A without Factor VIII Inhibitors

– In a subset of patients in the HAVEN 3 study who previously received factor VIII prophylaxis, the standard of care, HEMLIBRA reduced bleeds by 68 percent compared to their prior therapy – – Phase III HAVEN 4 results showed HEMLIBRA every four weeks provides clinically meaningful control of bleeding in people with or without factor VIII inh...

GenSight Biologics to Host KOL Event on June 12, 2018

Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (Paris:SIGHT), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that it will host a KOL Event on June 12, 2018 in New York City f...

20152023 World Automotive Telematics Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 23022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

How Telemedicine is Transforming the Doctor-Patient Relationship

Editor’s Note:  Melissa Powell is the COO of The Allure Group, a chain of skilled rehabilitation facilities in the New York area. As COO of The Allure Group, Melissa represents New York’s largest for-profit nursing home chain in Brooklyn, directly bettering the lives of 1400 patients currently receiving care in Allure’s 4 and 5 star ... Read More

Talion API Insight,2018 [Report Updated: 14022018] Prices from USD $500

IntroductionDelveInsight's, Talion API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Talion . The report also highlights the patent details of Talion . MethodologyThe report is built using data and information sourced from proprietary da...

Fixing the Clinical Trial Bottleneck by Making Patients a Priority

The world of medicine and drug development has transformed dramatically over the past 50 years. Today, we have biologic medicines, genomic sequencing technologies, and digital health tools that help patients become more engaged in their care. But one part of the equation hasn’t seen very much change at all: clinical trials. Clinical trials are a […]

Decrease in medication use among US children and adolescents

1. While overall prescribing of medications decreased compared to the early 2000s, the use of ADHD medication, asthma medicine, and contraceptive use increased while use of antibiotics, antihistamines, and upper respiratory combination medications decreased. 2. Most commonly used medication classes include asthma medications, antibiotics, ADHD medications, topical agents, and antihistamines.    ...

Patients with advanced adenomas are at increased risk of developing colorectal cancer

1. Patients with advanced adenomas identified on flex sigmoidoscopy had a significantly increased risk of death from colorectal cancer (CRC) compared to those with no adenomas. 2. There was no difference in cumulative CRC incidence in patients with nonadvanced adenomas as compared to those with no adenomas. Evidence Rating: 1 (Excellent) Study Rundown: Colorectal cancer […]

Children with autism missed by early screening show measurable differences at screening age

1. Children who pass screening for autism spectrum disorders (ASD) at 18 months, but who later go on develop ASD display delays and atypical behaviors in social, communicative and motor domains at time of screening, as measured by instruments beyond the standard screening. 2. Females missed by early ASD screening showed a different profile of […]

CareCloud Launches eCommerce Platform for Physician Practices, Breeze Shop

CareCloud, a Miami-based provider of cloud-based practice management and EHR solution for physician practices, today announced the launch of their new eCommerce platform, Breeze Shop. Breeze Shop makes it easier than ever for physician practices to make the products they recommend convenient for their patients to buy. This powerful eCommerce and over-the-counter retail solution enables ... Read Mo...

Sunday 20th May 2018

XuanZhu Pharma Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19032018] Prices from USD $250

SummaryXuanZhu Pharma Co Ltd XuanZhu, a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd is a healthcare company that research, develops, manufactures and sales drugs. The company's products include antiinfective drugs apapenem and benapenem; antiacid drug anaprazole sodium, antidiabetic drug imigliptin hydrochloride and antihypertensive drug tylerdipine hydrochloride. Its technology platfor...

Will 'Public Shaming' Sink Celgene?

Dr. Glenn Steele on the Path Forward Towards Care Delivery Transformation

Mark HaglandHealthcare Informatics caught up recently with Glenn D. Steele, Jr., M.D., Ph.D., who has been busy spreading the gospel of the Geisinger approach to healthcare delivery innovation, U.S. healthcare system-wide

Esmya Restriction In Europe Could Handcuff Allergan

The Jury's Still Out On Depomed

Valeant Pharmaceuticals: Worth At Least $30

Valeant: Much Ado About Nothing

Takeda Looks To The New As It Braces For Velcade Generics

Takeda is facing major revenue challenges from US generics to its big seller Velcade, but is looking to successor and...   

Takeda Bracing For Generic Velcade Storm

Takeda is facing major revenue challenges from US generics to its big seller Velcade, but is looking to successor and...   

Quick Search


BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.